Evidence map›Paper›PMID 26257172›Full record

ArticleCell reports2015

Exome Sequence Analysis Suggests that Genetic Burden Contributes to Phenotypic Variability and Complex Neuropathy.

Claudia Gonzaga-Jauregui, Tamar Harel, Tomasz Gambin, Maria Kousi, Laurie B Griffin, Ludmila Francescatto, Burcak Ozes, Ender Karaca, Shalini N Jhangiani, Matthew N Bainbridge and 25 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 165 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
165citing papers in PubMed, 1 pooled it
11.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

165 citing papers in PubMed, 1 synthesis or guideline pooled it, 244 citations in OpenAlex.

  1. Current profile of Charcot-Marie-Tooth disease in Africa: A systematic review.Journal of the peripheral nervous system : JPNS · 2022
    Pooled it
  2. Trial
  3. Article
  4. Tyrosine Supplementation Rescues a Growth Defect in a HumanizedInternational journal of molecular sciences · 2026
    Article
  5. Review
  6. Article
  7. PathogenicHuman mutation · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. High-Fat Diet Disrupt Nerve Function by Targeting Schwann Cells.Journal of the peripheral nervous system : JPNS · 2025
    Article
  14. Article
  15. Review
  16. Modeling of Charcot-Marie-Tooth disease in zebrafish.Frontiers in molecular neuroscience · 2025
    Review
  17. Article
  18. Article
  19. Article
  20. Impacts of Elevated COPlants (Basel, Switzerland) · 2024
    Article

105 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors at 12 institutions in 3 countries.

Claudia Gonzaga-JaureguiDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA; Center for Human Disease Modeling, Duke University, Durham, NC 27701, USA.
Tamar HarelDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Tomasz GambinDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Maria KousiCenter for Human Disease Modeling, Duke University, Durham, NC 27701, USA.
Laurie B GriffinCellular and Molecular Biology Program, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Medical Scientist Training Program, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Ludmila FrancescattoCenter for Human Disease Modeling, Duke University, Durham, NC 27701, USA.
Burcak OzesDepartment of Molecular Biology and Genetics, Bogazici University, Istanbul 34342, Turkey.
Ender KaracaDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Shalini N JhangianiHuman Genome Sequencing Center, Baylor College of Medicine, Houston, TX 77030, USA.
Matthew N BainbridgeHuman Genome Sequencing Center, Baylor College of Medicine, Houston, TX 77030, USA.
Kim S LawsonHuman Genetics Center and Institute of Molecular Medicine, University of Texas-Houston Health Science Center, Houston, TX 77030, USA.
Davut PehlivanDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Yuji OkamotoDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Marjorie WithersDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Pedro ManciasDivision of Child & Adolescent Neurology, Department of Neurology and Pediatrics, University of Texas Medical School at Houston, Houston, TX 77030, USA.
Anne SlavotinekDivision of Genetics, Department of Pediatrics, University of California, San Francisco, San Francisco, CA 94158, USA.
Pamela J ReitnauerPediatric Teaching Program, Cone Health System and UNC-Chapel Hill, Greensboro, NC 27401, USA.
Meryem T GoksungurDepartment of Neurology, Istanbul University, Istanbul Medical Faculty, Istanbul 34093, Turkey.
Michael ShyDepartment of Neurology, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.
Thomas O CrawfordDepartments of Neurology and Pediatrics, Johns Hopkins University, Baltimore, MD 21218, USA.
Michel KoenigInstitut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC), CNRS-INSERM-Universite de Strasbourg, Illkirch 67404, France; INSERM UMR_S 827, Institut Universitaire de Recherche Clinique and Laboratoire de Génétique Moléculaire, Centre Hospitalier Universitaire de Montpellier, Montpellier 34093, France.
Jason WillerCenter for Human Disease Modeling, Duke University, Durham, NC 27701, USA.
Brittany N FloresCellular and Molecular Biology Program, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Igor PediaditrakisCenter for Human Disease Modeling, Duke University, Durham, NC 27701, USA.
Onder UsDepartment of Neurology, Acibadem Kozyatagı Hospital, Istanbul 34742, Turkey.
Wojciech WiszniewskiDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Yesim ParmanDepartment of Neurology, Istanbul University, Istanbul Medical Faculty, Istanbul 34093, Turkey.
Anthony AntonellisCellular and Molecular Biology Program, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Human Genetics, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Neurology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Donna M MuznyHuman Genome Sequencing Center, Baylor College of Medicine, Houston, TX 77030, USA.
Baylor-Hopkins Center for Mendelian Genomics
Nicholas KatsanisCenter for Human Disease Modeling, Duke University, Durham, NC 27701, USA.
Esra BattalogluDepartment of Molecular Biology and Genetics, Bogazici University, Istanbul 34342, Turkey.
Eric BoerwinkleHuman Genome Sequencing Center, Baylor College of Medicine, Houston, TX 77030, USA; Human Genetics Center and Institute of Molecular Medicine, University of Texas-Houston Health Science Center, Houston, TX 77030, USA.
Richard A GibbsDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX 77030, USA.
James R LupskiDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX 77030, USA; Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA; Texas Children's Hospital, Houston, TX 77030, USA. Electronic address: jlupski@bcm.edu.
Baylor College of Medicine · USDuke University · USUniversity of Michigan–Ann Arbor · USBoğaziçi University · TRIstanbul University · TRAcıbadem Adana Hospital · TRCone Health · USInserm · FRJohns Hopkins University · USThe University of Texas Health Science Center at Houston · USUniversity of California, San Francisco · USUniversity of Iowa · US

Funding

The Human Genome Sequencing CenterU54HG003273 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI GIBBS, RICHARD A · 2004 to 2015
$341.3M
MICHIGAN MEDICAL SCIENTIST TRAINING PROGRAMT32GM007863 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI COLLINS, KATHLEEN L. · 1985 to 2024
$38.3M
Project 3P50MH094268 · NIMH · JOHNS HOPKINS UNIVERSITY · PI AVRAMOPOULOS, DIMITRIOS · 2011 to 2020
$19.9M
trainingU54NS065712 · NINDS · WAYNE STATE UNIVERSITY · PI SHY, MICHAEL E. · 2009 to 2023
$19.6M
Baylor-Johns Hopkins Center for Mendelian GeneticsU54HG006542 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI VALLE, DAVID · 2012 to 2015
$15.6M
CELLULAR AND MOLECULAR BIOLOGY AT MICHIGANT32GM007315 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PUTHENVEEDU, MANOJKUMAR A · 1985 to 2021
$12.8M
MEDICAL GENETICS RESEARCH FELLOWSHIP PROGRAMT32GM007526 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI Brendan Lee · 1985 to 2026
$11.4M
Nonrecurrent rearrangements, genome architecture and neurodegenerative disease.R01NS058529 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI LUPSKI, JAMES R. · 2009 to 2017
$5.0M
Genomic Studies in Charcot-Marie-Tooth DiseaseR01NS075764 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI SHY, MICHAEL E., ZUCHNER, STEPHAN · 2012 to 2016
$3.0M
Genome analysis to elucidate molecular mechanisms for peripheral neuropathiesK23NS078056 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI WISZNIEWSKI, WOJCIECH KRZYSZTOF · 2012 to 2016
$783k
The role of glycyl-tRNA synthetase in axonal health and diseaseF30NS092238 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GRIFFIN, LAURIE BETH · 2015 to 2016
$40k
NHGRI NIH HHS U54 HG003273NHGRI NIH HHS U54HG003273NHGRI NIH HHS U54 HG006542NHGRI NIH HHS U54HG006542NIGMS NIH HHS GM007315NIGMS NIH HHS GM07863NIGMS NIH HHS T32 GM007315NIGMS NIH HHS T32 GM007526NIGMS NIH HHS T32 GM007863NIGMS NIH HHS T32 GM07526-37NIMH NIH HHS P50 MH094268NINDS NIH HHS F30 NS092238NINDS NIH HHS K23 NS078056NINDS NIH HHS K23NS078056NINDS NIH HHS NS092238NINDS NIH HHS R01 NS058529NINDS NIH HHS R01NS058529NINDS NIH HHS R01 NS075764NINDS NIH HHS R01NS075764NINDS NIH HHS U54 NS065712NINDS NIH HHS U54NS065712
6 · The paper itself

Abstract

Charcot-Marie-Tooth (CMT) disease is a clinically and genetically heterogeneous distal symmetric polyneuropathy. Whole-exome sequencing (WES) of 40 individuals from 37 unrelated families with CMT-like peripheral neuropathy refractory to molecular diagnosis identified apparent causal mutations in ∼ 45% (17/37) of families. Three candidate disease genes are proposed, supported by a combination of genetic and in vivo studies. Aggregate analysis of mutation data revealed a significantly increased number of rare variants across 58 neuropathy-associated genes in subjects versus controls, confirmed in a second ethnically discrete neuropathy cohort, suggesting that mutation burden potentially contributes to phenotypic variability. Neuropathy genes shown to have highly penetrant Mendelizing variants (HPMVs) and implicated by burden in families were shown to interact genetically in a zebrafish assay exacerbating the phenotype established by the suppression of single genes. Our findings suggest that the combinatorial effect of rare variants contributes to disease burden and variable expressivity.

Indexed as

ExomeGenetic LoadPhenotypeAnimalsCharcot-Marie-Tooth DiseaseFemaleGenetic VariationHSP40 Heat-Shock ProteinsHumansMaleMutationMyelin P2 ProteinPedigreePenetrancePeripheral Nervous System DiseasesSerine C-PalmitoyltransferaseDNAJB5 protein, humanHSP40 Heat-Shock ProteinsMyelin P2 ProteinPMP2 protein, humanSerine C-PalmitoyltransferaseSPTLC3 protein, human

Identifiers

PMID26257172
PMCPMC4545408
OpenAlexW1654401488

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.